# Kura Oncology, Inc.: Form 8-K, filed Jun 7, 2024

- Company: [Kura Oncology, Inc.](/companies/kura.md) (CIK 1422143)
- Form: 8-K
- Filed: 2024-06-07
- Accepted by EDGAR: Jun 7, 2024, 16:05 ET
- Period: 2024-06-05
- Accession: 0000950170-24-070584
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1422143/000095017024070584/kura-20240605.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1422143/000095017024070584/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1422143/000095017024070584/kura-20240605.htm

Filed Jun 7, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-070584. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.